Rolvedon Receives FDA Approval to Prevent Chemotherapy-Related Infections
XTalks
OCTOBER 4, 2022
Rolvedon is indicated to lower the chance of infection from febrile neutropenia (the development of fever, often with other signs of infection, in patients with a very low number of neutrophil granulocytes in the blood) in adult patients with non-myeloid malignancies on myelosuppressive anti-cancer drugs. How Does Rolvedon Work?
Let's personalize your content